DST Inspire / Ramanujan / Ramalingaswami Fellows at BITS Pilani
State of the art laboratory infrastructure to support and promote high quality as well as interdisciplinary research in different pure and applied areas. Support to set up collaborative research.
Opportunity for Nasal and Ophthalmic Manufacturing at JAMP group - M.Pharm, B.Pharm, MSc Apply
Proficient in testing raw materials, finished products, and stability samples for Nasal formulations. Knowledge of method validation, calibration, and qualification activities.
Openings in Regulatory Affairs at Biological E. Limited
Responsible for Preparation of Regulatory Documents for submission to Indian Regulatory Authorities. Experienced in handling, management and expansion of product portfolios, markets/ territories.
Openings for M.Pharm, B.Pharm, MSc in QA, QC, Production at Immacule Lifesciences
Immacule Lifesciences Pvt. Ltd. is expanding and looking for passionate professionals with Regulatory Exposure and Sterile Experience to join our growing team.
Walk in Drive for M.Pharm, B.Pharm, MSc in Production, QA, QC at Macleods
2-8 years of experience in API Plant Analytical Compliance, Cleaning Sampling, RA Co-Ordination. Process Validation, QMS,Training Co-Ordination, IPQA.
Tiefenbacher Pharmaceuticals Hiring B.Pharm, M.Pharm in Development Quality Assurance
Responsible for investigations related to Laboratory incidents, OOS, OOT, OOE, failure investigations and participating / involving in these investigations
Multiple Openings at Lactose India - M.Pharm, B.Pharm, MSc Apply
B.Pharm / M.Pharm / BSc / MSc; Lactose India Limited is a young and innovative company specializing in the manufacturing of Excipients Lactose / Colour Coatings, Lactulose, Solid Dosage Forms, Liquid Dosage Forms, at Vadodara, Gujarat.
Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide

Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing and commercializing high-quality medicines, announced that its fourth Phase 3 clinical trial, DREAMS-3, evaluating mazdutide, a dual glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptor agonist met its primary endpoint.

Dr Reddy’s to Launch Generic Version of Wegovy in 87 Countries Next Year
Dr Reddys Laboratories Ltd, one of Indias leading pharmaceutical companies, plans to launch a lower-cost generic version of Novo Nordisks blockbuster weight-loss drug Wegovy across 87 countries next year, according to the company’s Chief Executive Officer, Erez Israeli.
Blenrep approved by USFDA for use in treatment of relapsed/refractory multiple myeloma
GSK plc announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory (IMID) agent.